Tuberculosis Diagnostics Market to be Worth $3.56 Billion by 2031

Tuberculosis Diagnostics Market Size, Share, Forecast, & Trends Analysis by Test Type (Mantoux, IGRA, Radiography [X-ray, CT] Molecular [NAAT, WGS, Rapid] Culture, Sputum Smear), End User (Hospital, Diagnostic Lab), Infection Stage – Global Forecast to 2031

Meticulous Research^®—a leading global market research company, published a research report titled, ‘Tuberculosis Diagnostics Market Size, Share, Forecast, & Trends Analysis by Test Type (Mantoux, IGRA, Radiography [X-ray, CT] Molecular [NAAT, WGS, Rapid] Culture, Sputum Smear) End User (Hospital, Diagnostic Lab) Infection Stage – Global Forecast to 2031’

According to this latest publication from Meticulous Research®, the tuberculosis diagnostics market is projected to reach $3.56 billion by 2031, at a CAGR of 5% during the forecast period 2024–2031. The growth of this market can be attributed to the rising prevalence of tuberculosis in low—and middle-income countries, the emergence of drug-resistant strains, and favorable initiatives for TB diagnosis and treatment. Moreover, initiatives by governments and organizations to raise awareness regarding tuberculosis are expected to generate growth opportunities for the players operating in the tuberculosis diagnostics market.

Key Players

The key players operating in tuberculosis diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), Abbott Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN GmbH (Germany), Hologic, Inc. (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), Oxford Immunotec Ltd. (U.K.), Hain Lifescience GmbH (Germany), Creative Diagnostics (U.S.).

Tuberculosis Diagnostics Market: Future Outlook

The tuberculosis diagnostics market is segmented by Test type (Skin Test, Interferon Gamma Release Assay, Radiographic Tests [Chest X-rays, Computed Tomography], Molecular Tests, Sputum Smear Microscopy, Culture & Drug Resistance, Other Test Types), Infection Stage (Active, Latent), End User (Diagnostic Laboratories, Hospitals & Clinics, Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

Based on test type, the market is segmented into skin test/Mantoux, radiographic tests, molecular tests, sputum smear microscopy, culture & drug resistance tests, and other test types. In 2024, the skin test/Mantoux segment is expected to account for the largest share of 38.2% of the tuberculosis diagnostics market. The large market share of this segment is attributed to the simplicity of the test, its low cost, and the wide availability of tests in even small clinics and remote areas. Furthermore, the high use of skin tests to test for latent TB infection further contributes to the large segment share. A skin test is one of the cheapest tests for tuberculosis; according to several research studies, the skin test for TB costs around USD 37, while the Interferon Gamma Release Assay (IGRA) costs around USD 89.

Based on infection stage, the tuberculosis diagnostics market is segmented into active and latent. The active segment is expected to register the highest CAGR during the forecast period of 2024-2031. This growth can be attributed to the increasing prevalence of tuberculosis in low- and middle-income countries, aims and goals set by the governments and public organizations to manage the TB burden, and growing instances of TB outbreaks.

Based on end user, the tuberculosis diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, academic & research institutes, and other end users. The diagnostic laboratories segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the growing use of advanced technologies for TB diagnoses, such as next-generation sequencing, which can be afforded by diagnostic laboratories as opposed to clinics & small -medium-sized hospitals, and initiatives by governments and organizations to raise awareness regarding tuberculosis.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, Indonesia, Thailand, Singapore, Philippines, Australia, and Rest of Asia-Pacific), Latin America, Middle East, Africa (South Africa, Nigeria, Kenya, Rest of Africa).

Based on geography, Asia-Pacific is projected to register the highest CAGR during the forecast period. Among all the Asia-Pacific countries, India & China offer lucrative opportunities for the players operating in the tuberculosis diagnostic market. India and China present lucrative opportunities in the tuberculosis diagnostic market due to their large populations, high burden of tuberculosis cases, and increasing healthcare investments, driving demand for diagnostic tools and technologies. Additionally, both countries have growing economies, which can support investments in healthcare infrastructure and research and development efforts in tuberculosis testing.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5885

Key questions answered in the report-

What is the current value of revenue generated by sales of tuberculosis diagnostic tests across the globe?
At what rate is the demand for tuberculosis diagnostic tests projected to grow for the next 5-7 years?
What is the historical market size and growth rate for tuberculosis diagnostic tests across the globe?
What are the major factors impacting the growth of this market at the regional level? What are the major opportunities for existing market players and new entrants in the market?
Which segments are creating major traction for the vendors in this market in terms of test type, infection stage, and end user?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the tuberculosis diagnostics market?
Who are the major players in the tuberculosis diagnostics market? And what are their specific apps offered in the industry?
What recent developments have taken place in the tuberculosis diagnostics market, and how these strategic developments are creating a global impact in this market?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research